Gefitinib(Iressa)

Another Name吉非替尼片、易瑞沙、伊瑞可、Gefitinib、Iressa

IndicationsIt is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have been confirmed to harbor EGFR exon 19 deletions or exon 21 (L858R) substitution mu